Pharmacist Involvement Improves Reimbursement of Biologics, Paper Says
November 6th 2018
By Kelly Davio
ArticleAt the Department of Abdominal Oncology at the National Cancer Institute of Naples in Italy, an expert pharmacist was involved in evaluating the economic impact of improving the Italian registry of high-cost drugs, particularly bevacizumab, cetuximab, panitumumab, and trastuzumab.